Literature DB >> 12690061

Executive and visuospatial deficits in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome.

Simone Bosbach1, Cornelia Kornblum, Rolf Schröder, Michael Wagner.   

Abstract

Although neuropsychological deficits have been reported in mitochondrial cytopathies, patients with chronic progressive external ophthalmoplegia (CPEO) or Kearns-Sayre syndrome (KSS) have not been studied systematically using a comprehensive test battery. The aim of our study was to assess the range and extent of putative cognitive dysfunction in 22 patients with CPEO or KSS, and to compare cognitive performance of patients with healthy control subjects matched for age, sex and years of education. Genetic analysis of skeletal muscle tissue from 22 patients with CPEO or KSS included screening for mitochondrial DNA (mtDNA) point mutations (3243/8344) and mtDNA deletions. All patients were examined by a neuropsychological test battery covering verbal skills, verbal and visual memory, visuo-spatial perception, visual construction, attention, abstraction and flexibility, and Quality of Life. Molecular genetic analysis of mtDNA revealed single large-scale deletions in 15 out of 22 patients and the tRNA (Leu) A3243G point mutation in two out of 22 patients. In five out of 22 patients none of the frequently encountered mtDNA mutations could be detected. Neuropsychological testing did not reveal general intellectual deterioration, but specific cognitive deficits, particularly in visual construction, attention and abstraction/flexibility. Subgroup analysis of 15 patients with mtDNA deletions showed similar results when compared with the full group. In our series of patients with CPEO or KSS neuropsychological testing did not reveal signs that would suggest general intellectual decline or dementia, but provided evidence of specific focal neuropsychological deficits, suggesting particular impairment of visuospatial perception associated to parieto-occipital lobes and executive deficits associated to the prefrontal cortex.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12690061     DOI: 10.1093/brain/awg101

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  16 in total

Review 1.  The genetics of strabismus.

Authors:  M Michaelides; A T Moore
Journal:  J Med Genet       Date:  2004-09       Impact factor: 6.318

Review 2.  Stem cell-based models and therapies for neurodegenerative diseases.

Authors:  Shilpa Iyer; Khaled Alsayegh; Sheena Abraham; Raj R Rao
Journal:  Crit Rev Biomed Eng       Date:  2009

3.  A conceptual disease model for quality of life in mitochondrial disease.

Authors:  Kim F E van de Loo; Nander T van Zeijl; Mirian C H Janssen; Christianne M Verhaak; José A E Custers
Journal:  Orphanet J Rare Dis       Date:  2022-07-15       Impact factor: 4.303

4.  Neuropsychological and Psychiatric Features of Children and Adolescents Affected With Mitochondrial Diseases: A Systematic Review.

Authors:  Elise Riquin; Philippe Duverger; Cindy Cariou; Magalie Barth; Clément Prouteau; Patrick Van Bogaert; Dominique Bonneau; Arnaud Roy
Journal:  Front Psychiatry       Date:  2020-07-28       Impact factor: 4.157

5.  Cognitive deficits in adult m.3243A>G- and m.8344A>G-related mitochondrial disease: importance of correcting for baseline intellectual ability.

Authors:  Heather L Moore; Thomas Kelly; Alexandra Bright; Robert H Field; Andrew M Schaefer; Alasdair P Blain; Robert W Taylor; Robert McFarland; Doug M Turnbull; Gráinne S Gorman
Journal:  Ann Clin Transl Neurol       Date:  2019-03-27       Impact factor: 4.511

6.  Heterogeneous patterns of tissue injury in NARP syndrome.

Authors:  Jeffrey M Gelfand; Jacque L Duncan; Caroline A Racine; Leslie A Gillum; Cynthia T Chin; Yuhua Zhang; Qing Zhang; Lee-Jun C Wong; Austin Roorda; Ari J Green
Journal:  J Neurol       Date:  2010-10-16       Impact factor: 4.849

7.  Hypoparathyroidism as the first manifestation of kearns-sayre syndrome: a case report.

Authors:  Farah Ashrafzadeh; Nosrat Ghaemi; Javad Akhondian; Mehran Beiraghi Toosi; Saghi Elmi
Journal:  Iran J Child Neurol       Date:  2013

8.  Clinical and Molecular Characteristics in 100 Chinese Pediatric Patients with m.3243A>G Mutation in Mitochondrial DNA.

Authors:  Chang-Yu Xia; Yu Liu; Hui Liu; Yan-Chun Zhang; Yi-Nan Ma; Yu Qi
Journal:  Chin Med J (Engl)       Date:  2016-08-20       Impact factor: 2.628

9.  Double trouble progressive external ophthalmoplegia and Huntington's disease.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Mol Genet Metab Rep       Date:  2016-04-19

Review 10.  Review: Central nervous system involvement in mitochondrial disease.

Authors:  N Z Lax; G S Gorman; D M Turnbull
Journal:  Neuropathol Appl Neurobiol       Date:  2016-07-07       Impact factor: 8.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.